Read + Share
Amedeo Smart
Independent Medical Education
Jain NK, Tailang M, Thangavel N, Makeen HA, et al. A comprehensive overview of selective and novel fibroblast growth factor receptor inhibitors as a potential anticancer modality. Acta Pharm 2024;74:1-36.PMID: 38554385
Email
LinkedIn
Facebook
Twitter
Privacy Policy